BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liedhegner ES, Vogt CD, Sem DS, Cunningham CW, Hillard CJ. Sterol carrier protein-2: binding protein for endocannabinoids. Mol Neurobiol 2014;50:149-58. [PMID: 24510313 DOI: 10.1007/s12035-014-8651-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Maccarrone M. Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years. Front Mol Neurosci 2017;10:166. [PMID: 28611591 DOI: 10.3389/fnmol.2017.00166] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 11.4] [Reference Citation Analysis]
2 Milligan S, Martin GG, Landrock D, McIntosh AL, Mackie JT, Schroeder F, Kier AB. Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:323-38. [PMID: 29307784 DOI: 10.1016/j.bbalip.2017.12.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hillard CJ, Huang H, Vogt CD, Rodrigues BE, Neumann TS, Sem DS, Schroeder F, Cunningham CW. Endocannabinoid Transport Proteins: Discovery of Tools to Study Sterol Carrier Protein-2. Methods Enzymol 2017;593:99-121. [PMID: 28750817 DOI: 10.1016/bs.mie.2017.06.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
4 Martin GG, Huang H, Mcintosh AL, Kier AB, Schroeder F. Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant. Biochemistry 2017;56:5147-59. [DOI: 10.1021/acs.biochem.7b00647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Martin GG, Seeger DR, McIntosh AL, Milligan S, Chung S, Landrock D, Dangott LJ, Golovko MY, Murphy EJ, Kier AB, Schroeder F. Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet. Lipids 2019;54:583-601. [PMID: 31487051 DOI: 10.1002/lipd.12192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Martin GG, Seeger DR, McIntosh AL, Chung S, Milligan S, Landrock D, Dangott LJ, Golovko MY, Murphy EJ, Kier AB, Schroeder F. Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat. Arch Biochem Biophys 2018;650:93-102. [PMID: 29763591 DOI: 10.1016/j.abb.2018.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Seillier A, Giuffrida A. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release. Neuropharmacology 2018;130:1-9. [DOI: 10.1016/j.neuropharm.2017.11.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Huang H, McIntosh AL, Martin GG, Dangott LJ, Kier AB, Schroeder F. Structural and Functional Interaction of Δ9-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1). Biochemistry 2018;57:6027-42. [PMID: 30232874 DOI: 10.1021/acs.biochem.8b00744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu C, Li H, Tang CK. Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications. Metabolism 2022;:155180. [PMID: 35311663 DOI: 10.1016/j.metabol.2022.155180] [Reference Citation Analysis]
10 Alhouayek M, Sorti R, Gilthorpe JD, Fowler CJ. Role of pannexin-1 in the cellular uptake, release and hydrolysis of anandamide by T84 colon cancer cells. Sci Rep 2019;9:7622. [PMID: 31110238 DOI: 10.1038/s41598-019-44057-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Parks C, Rogers CM, Prins P, Williams RW, Chen H, Jones BC, Moore BM 2nd, Mulligan MK. Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice. Front Genet 2021;12:659012. [PMID: 34367237 DOI: 10.3389/fgene.2021.659012] [Reference Citation Analysis]
12 Miralpeix C, Reguera AC, Fosch A, Zagmutt S, Casals N, Cota D, Rodríguez-Rodríguez R. Hypothalamic endocannabinoids in obesity: an old story with new challenges. Cell Mol Life Sci 2021;78:7469-90. [PMID: 34718828 DOI: 10.1007/s00018-021-04002-6] [Reference Citation Analysis]
13 Hillard CJ. The Endocannabinoid Signaling System in the CNS: A Primer. Int Rev Neurobiol. 2015;125:1-47. [PMID: 26638763 DOI: 10.1016/bs.irn.2015.10.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
14 Cunningham CW. Plant-Based Modulators of Endocannabinoid Signaling. J Nat Prod 2019;82:636-46. [PMID: 30816712 DOI: 10.1021/acs.jnatprod.8b00874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Della Pietra A, Savinainen J, Giniatullin R. Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. Int J Mol Sci 2022;23:4407. [PMID: 35457225 DOI: 10.3390/ijms23084407] [Reference Citation Analysis]
16 Martin GG, Chung S, Landrock D, Landrock KK, Huang H, Dangott LJ, Peng X, Kaczocha M, Seeger DR, Murphy EJ, Golovko MY, Kier AB, Schroeder F. FABP-1 gene ablation impacts brain endocannabinoid system in male mice. J Neurochem 2016;138:407-22. [PMID: 27167970 DOI: 10.1111/jnc.13664] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
17 Nicolussi S, Chicca A, Rau M, Rihs S, Soeberdt M, Abels C, Gertsch J. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: From ultrapotent to hyperpotent. Biochemical Pharmacology 2014;92:669-89. [DOI: 10.1016/j.bcp.2014.09.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
18 Martin GG, Chung S, Landrock D, Landrock KK, Dangott LJ, Peng X, Kaczocha M, Murphy EJ, Kier AB, Schroeder F. Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels. Lipids 2016;51:1007-20. [PMID: 27450559 DOI: 10.1007/s11745-016-4175-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
19 Nicolussi S, Gertsch J. Endocannabinoid transport revisited. Vitam Horm 2015;98:441-85. [PMID: 25817877 DOI: 10.1016/bs.vh.2014.12.011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 8.6] [Reference Citation Analysis]
20 Meccariello R, Santoro A, D'Angelo S, Morrone R, Fasano S, Viggiano A, Pierantoni R. The Epigenetics of the Endocannabinoid System. Int J Mol Sci 2020;21:E1113. [PMID: 32046164 DOI: 10.3390/ijms21031113] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
21 Kaczocha M, Haj-Dahmane S. Mechanisms of endocannabinoid transport in the brain. Br J Pharmacol 2021. [PMID: 33786823 DOI: 10.1111/bph.15469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ruiz de Azua I, Lutz B. Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues. Cell Mol Life Sci 2019;76:1341-63. [PMID: 30599065 DOI: 10.1007/s00018-018-2994-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]